1. Ma, L. Y. et al. China cardiovascular diseases report 2018: anupdated summary. J Geriatr Cardiol 17,1-8 (2020).
2. Ferini-Strambi, L., Fantini, M. L. & Castronovo, C. Epidemiology of obstructive sleep apnea syndrome. Minerva Med 95, 187-202 (2004).
3. Gottlieb, D. J. & Punjabi, N. M. Diagnosis and Management of Obstructive Sleep Apnea: A Review. JAMA 323, 1389-1400 (2020).
4. McEvoy, R. D. et al. SAVE Investigators and Coordinators. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 375, 919-931 (2016).
5. Benjafield, A. V. et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7, 687-698 (2019).
6. Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41, 1429-1437 (2003).
7. Coughlin, S. R., Mawdsley, L., Mugarza, J. A., Calverley, P. M. A. & Wilding, J. P. H. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25, 735-741 (2004).
8. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353, 2034-2041 (2005).
9. Drager, L. F., Togeiro, S. M., Polotsky, V. Y. & Lorenzi-Filho, G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 62, 569-576 (2013).
10. Gami, A. S. et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 62, 610-616 (2013).
11. Cadby, G. et al. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest 148, 945-952 (2015).
12. Yu, J. et al. Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis. JAMA 318, 156-166 (2017).
13. Hu, C. S., Wu, Q. H., Hu, D. Y. & Tkebuchava, T. Novel strategies halt cardiovascular, diabetes, and cancer strips. Chronic Dis Transl Med 3, 159-164 (2017).
14. Wolk, R., Shamsuzzaman, A. S. & Somers, V. K. Obesity, sleep apnea, and hypertension. Hypertension 42, 1067-1074 (2003).
15. Schulz, R. et al. Vaskuläre Folgeerkrankungen bei obstruktiver Schlafapnoe [Obstructive sleep apnea-related cardiovascular disease]. Med Klin (Munich) 101, 321-327 (2006).
16. Ryan, S. Mechanisms of cardiovascular disease in obstructive sleep apnoea. J Thorac Dis 10, S4201-S4211 (2018).
17. Durgan, D. J. Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota. Curr Hypertens Rep 19, 35 (2017).
18. Farré, N., Farré, R. & Gozal, D. Sleep Apnea Morbidity: A Consequence of Microbial-Immune Cross-Talk? Chest 154, 754-759 (2018).
19. Rocchini, A. P., Moorehead, C., Wentz, E. & Deremer, S. Obesity-induced hypertension in the dog. Hypertension 9, III64- III68 (1987).
20. Kimoff, R. J. et al. Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol 76, 1810-1817 (1994).
21. Frayling, T. M. et al. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity. Science 316, 889-894 (2007).
22. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206 (2015).
23. Bhattacharjee R, Kim J, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D. Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea. Chest 141, 682-691 (2012).
24. Shi, T. et al. Genetic variants of rs1275988 and rs2586886 in TWIK-related acid-sensitive K+ channel-1 gene may be potential risk factors for obese patients with obstructive sleep apnea. Chin Med J (Engl) 132, 2059-2065 (2019).
25. Moreno, C. R. et al. High risk for obstructive sleep apnea in truck drivers estimated by the Berlin questionnaire: prevalence and associated factors. Chronobiol Int 21, 871-879 (2004).
26. Johnson, D. A. et al. Association Between Sleep Apnea and Blood Pressure Control Among Blacks. Circulation 139, 1275-1284 (2019).
27. Broström, A. et al. Gender differences in respiratory disturbance, sleep and daytime sleepiness in hypertensive patients with different degrees of obesity. Eur J Cardiovasc Nurs 12, 140-149 (2013).
28. Quintana-Gallego, E. et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med 98, 984-989 (2004).
29. Temple, K. A. et al. Sex Differences in the Impact of Obstructive Sleep Apnea on Glucose Metabolism. Front Endocrinol (Lausanne) 9, 376 (2018).
30. Hu, C. Grants supporting research in China. Eur Heart J 39, 2342-2344 (2018).
31. Hu, C. S. & Tkebuchava, T. SEEDi1.0–3.0 strategies for major noncommunicable diseases in China. J Integr Med 15, 265-269 (2017).
32. Sin, D. D. et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 123, 1536-1543 (2003).
33. Li, J. et al. Self-reported Snoring Patterns Predict Stroke Events in High-Risk Patients With OSA: Post Hoc Analyses of the SAVE Study. Chest 158, 2146-2154 (2020).
34. Pi-Sunyer, X. et al. SCALE Obesity and Prediabetes NN8022-1839 Study Group. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med 373, 11-22 (2015).
35. Bohula, E. A. et al. CAMELLIA–TIMI 61 Steering Committee and Investigators. Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. N Engl J Med 379, 1107-1117 (2018).
36. Wolk, R. & Somers, V. K. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab 8, 250-260 (2006).
37. Sánchez-de-la-Torre, M. et al. Spanish Sleep Network. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med 8, 359-367 (2020).
38. Ou, Q. et al. SAVE investigators. The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular Disease: Data From the SAVE Trial. Chest 155, 720-729 (2019).
39. Purkayastha, S., Zhang, G. & Cai, D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nat Med 17, 883-887 (2011).
40. Asai, M. et al. Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity. Science 341, 275-278 (2013).
41. Baron, M. et al. Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension. Nat Med 25, 1733-1738 (2019).
42. Sakaue, S. et al. Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan. Nat Med 26, 542-548 (2020).
43. Hu, C. S. C-type Hypertension. Eur Heart J 40, 715 (2019).
44. MacKay, S. et al. Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial. JAMA 324, 1168-1179 (2020).
45. Hu, C. S., Wu, Q. H. & Hu, D. Y. Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications. J Thorac Dis 6, 1319-1328 (2014).